nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCB—stomach cancer	0.0371	0.161	CbGpPWpGaD
Hydralazine—AOC3—blood vessel—stomach cancer	0.0299	0.121	CbGeAlD
Hydralazine—RYR2—smooth muscle tissue—stomach cancer	0.0233	0.0942	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNA2—stomach cancer	0.0213	0.0927	CbGpPWpGaD
Hydralazine—RYR2—Stimuli-sensing channels—CLCN3—stomach cancer	0.0196	0.0851	CbGpPWpGaD
Hydralazine—AOC3—hematopoietic system—stomach cancer	0.0159	0.0644	CbGeAlD
Hydralazine—RYR2—endocrine gland—stomach cancer	0.0152	0.0614	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—stomach cancer	0.0148	0.0642	CbGpPWpGaD
Hydralazine—AOC3—smooth muscle tissue—stomach cancer	0.014	0.0567	CbGeAlD
Hydralazine—AOC3—pancreas—stomach cancer	0.013	0.0524	CbGeAlD
Hydralazine—RYR2—Ion channel transport—CLCN3—stomach cancer	0.0128	0.0556	CbGpPWpGaD
Hydralazine—P4HA1—hematopoietic system—stomach cancer	0.0127	0.0515	CbGeAlD
Hydralazine—P4HA1—smooth muscle tissue—stomach cancer	0.0112	0.0453	CbGeAlD
Hydralazine—AOC3—lymphoid tissue—stomach cancer	0.0112	0.0453	CbGeAlD
Hydralazine—AOC3—digestive system—stomach cancer	0.0111	0.0448	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA5—stomach cancer	0.0108	0.0469	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA8—stomach cancer	0.0104	0.0453	CbGpPWpGaD
Hydralazine—P4HA1—pancreas—stomach cancer	0.0104	0.0419	CbGeAlD
Hydralazine—AOC3—bone marrow—stomach cancer	0.0102	0.0413	CbGeAlD
Hydralazine—AOC3—endocrine gland—stomach cancer	0.00916	0.037	CbGeAlD
Hydralazine—P4HA1—lymphoid tissue—stomach cancer	0.00897	0.0362	CbGeAlD
Hydralazine—AOC3—liver—stomach cancer	0.00826	0.0334	CbGeAlD
Hydralazine—P4HA1—bone marrow—stomach cancer	0.00817	0.033	CbGeAlD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ACTC1—stomach cancer	0.00759	0.0331	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CDH2—stomach cancer	0.00741	0.0322	CbGpPWpGaD
Hydralazine—P4HA1—endocrine gland—stomach cancer	0.00732	0.0296	CbGeAlD
Hydralazine—P4HA1—liver—stomach cancer	0.0066	0.0267	CbGeAlD
Hydralazine—AOC3—lymph node—stomach cancer	0.00633	0.0256	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	0.00511	0.0222	CbGpPWpGaD
Hydralazine—P4HA1—lymph node—stomach cancer	0.00506	0.0204	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—RORA—stomach cancer	0.00498	0.0217	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—RGS2—stomach cancer	0.00495	0.0215	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—RUNX3—stomach cancer	0.00487	0.0212	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HSPD1—stomach cancer	0.00458	0.0199	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00444	0.0193	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IGFBP3—stomach cancer	0.00389	0.0169	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.00359	0.0156	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB1—stomach cancer	0.00348	0.0152	CbGpPWpGaD
Hydralazine—CYP3A4—hematopoietic system—stomach cancer	0.00338	0.0136	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.00336	0.0146	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB2—stomach cancer	0.00282	0.0123	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.00252	0.011	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL10—stomach cancer	0.0024	0.0105	CbGpPWpGaD
Hydralazine—CYP3A4—digestive system—stomach cancer	0.00235	0.00949	CbGeAlD
Hydralazine—CYP3A4—endocrine gland—stomach cancer	0.00194	0.00784	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	0.00193	0.00842	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00193	0.00842	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCB—stomach cancer	0.00187	0.00816	CbGpPWpGaD
Hydralazine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.00182	0.00791	CbGpPWpGaD
Hydralazine—CYP3A4—liver—stomach cancer	0.00175	0.00707	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.00166	0.00722	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—stomach cancer	0.00149	0.00648	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.00147	0.0064	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.00137	0.00597	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.00131	0.00572	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—stomach cancer	0.00127	0.00552	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.00126	0.00549	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—JUN—stomach cancer	0.00123	0.00535	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—JUN—stomach cancer	0.00122	0.00532	CbGpPWpGaD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.00118	0.00513	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.00107	0.00465	CbGpPWpGaD
Hydralazine—Renal failure acute—Doxorubicin—stomach cancer	0.00104	0.00198	CcSEcCtD
Hydralazine—Hepatitis—Capecitabine—stomach cancer	0.00103	0.00197	CcSEcCtD
Hydralazine—Thrombocytopenia—Fluorouracil—stomach cancer	0.00102	0.00196	CcSEcCtD
Hydralazine—Hypoaesthesia—Capecitabine—stomach cancer	0.00102	0.00196	CcSEcCtD
Hydralazine—Tachycardia—Fluorouracil—stomach cancer	0.00102	0.00195	CcSEcCtD
Hydralazine—Hypotension—Irinotecan—stomach cancer	0.00102	0.00195	CcSEcCtD
Hydralazine—Anorexia—Fluorouracil—stomach cancer	0.000996	0.0019	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—stomach cancer	0.000993	0.0019	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000985	0.00429	CbGpPWpGaD
Hydralazine—Flushing—Docetaxel—stomach cancer	0.000985	0.00188	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—stomach cancer	0.000981	0.00188	CcSEcCtD
Hydralazine—Paraesthesia—Irinotecan—stomach cancer	0.000979	0.00187	CcSEcCtD
Hydralazine—Hypotension—Fluorouracil—stomach cancer	0.000976	0.00187	CcSEcCtD
Hydralazine—Dyspnoea—Irinotecan—stomach cancer	0.000972	0.00186	CcSEcCtD
Hydralazine—Dyspepsia—Irinotecan—stomach cancer	0.00096	0.00184	CcSEcCtD
Hydralazine—Flushing—Capecitabine—stomach cancer	0.000954	0.00182	CcSEcCtD
Hydralazine—Chills—Docetaxel—stomach cancer	0.000952	0.00182	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000952	0.00182	CcSEcCtD
Hydralazine—Decreased appetite—Irinotecan—stomach cancer	0.000948	0.00181	CcSEcCtD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.000948	0.00413	CbGpPWpGaD
Hydralazine—Eosinophilia—Methotrexate—stomach cancer	0.000946	0.00181	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000942	0.0018	CcSEcCtD
Hydralazine—Paraesthesia—Fluorouracil—stomach cancer	0.000938	0.00179	CcSEcCtD
Hydralazine—Constipation—Irinotecan—stomach cancer	0.000933	0.00178	CcSEcCtD
Hydralazine—Dyspnoea—Fluorouracil—stomach cancer	0.000931	0.00178	CcSEcCtD
Hydralazine—Chills—Capecitabine—stomach cancer	0.000922	0.00176	CcSEcCtD
Hydralazine—Dyspepsia—Fluorouracil—stomach cancer	0.000919	0.00176	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—stomach cancer	0.000915	0.00398	CbGpPWpGaD
Hydralazine—Decreased appetite—Fluorouracil—stomach cancer	0.000908	0.00174	CcSEcCtD
Hydralazine—Pancytopenia—Methotrexate—stomach cancer	0.000907	0.00174	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000902	0.00173	CcSEcCtD
Hydralazine—Feeling abnormal—Irinotecan—stomach cancer	0.000899	0.00172	CcSEcCtD
Hydralazine—Neutropenia—Methotrexate—stomach cancer	0.000893	0.00171	CcSEcCtD
Hydralazine—Dysuria—Methotrexate—stomach cancer	0.000893	0.00171	CcSEcCtD
Hydralazine—Muscle spasms—Docetaxel—stomach cancer	0.000888	0.0017	CcSEcCtD
Hydralazine—Eosinophilia—Epirubicin—stomach cancer	0.000885	0.00169	CcSEcCtD
Hydralazine—Angina pectoris—Epirubicin—stomach cancer	0.000871	0.00167	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000871	0.00379	CbGpPWpGaD
Hydralazine—Body temperature increased—Irinotecan—stomach cancer	0.000862	0.00165	CcSEcCtD
Hydralazine—Feeling abnormal—Fluorouracil—stomach cancer	0.000861	0.00165	CcSEcCtD
Hydralazine—Muscle spasms—Capecitabine—stomach cancer	0.00086	0.00164	CcSEcCtD
Hydralazine—Anaemia—Docetaxel—stomach cancer	0.000854	0.00163	CcSEcCtD
Hydralazine—Depression—Methotrexate—stomach cancer	0.00085	0.00163	CcSEcCtD
Hydralazine—Pancytopenia—Epirubicin—stomach cancer	0.000849	0.00162	CcSEcCtD
Hydralazine—Tremor—Capecitabine—stomach cancer	0.000838	0.0016	CcSEcCtD
Hydralazine—Dysuria—Epirubicin—stomach cancer	0.000836	0.0016	CcSEcCtD
Hydralazine—Neutropenia—Epirubicin—stomach cancer	0.000836	0.0016	CcSEcCtD
Hydralazine—Ill-defined disorder—Capecitabine—stomach cancer	0.00083	0.00159	CcSEcCtD
Hydralazine—Urticaria—Fluorouracil—stomach cancer	0.00083	0.00159	CcSEcCtD
Hydralazine—Conjunctivitis—Methotrexate—stomach cancer	0.000828	0.00158	CcSEcCtD
Hydralazine—Leukopenia—Docetaxel—stomach cancer	0.000827	0.00158	CcSEcCtD
Hydralazine—Anaemia—Capecitabine—stomach cancer	0.000827	0.00158	CcSEcCtD
Hydralazine—Body temperature increased—Fluorouracil—stomach cancer	0.000826	0.00158	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—stomach cancer	0.000819	0.00157	CcSEcCtD
Hydralazine—Palpitations—Docetaxel—stomach cancer	0.000816	0.00156	CcSEcCtD
Hydralazine—Haematuria—Methotrexate—stomach cancer	0.000812	0.00155	CcSEcCtD
Hydralazine—Weight decreased—Epirubicin—stomach cancer	0.000809	0.00155	CcSEcCtD
Hydralazine—Malaise—Capecitabine—stomach cancer	0.000807	0.00154	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—stomach cancer	0.000806	0.00154	CcSEcCtD
Hydralazine—Hypersensitivity—Irinotecan—stomach cancer	0.000804	0.00154	CcSEcCtD
Hydralazine—Leukopenia—Capecitabine—stomach cancer	0.000801	0.00153	CcSEcCtD
Hydralazine—Agranulocytosis—Methotrexate—stomach cancer	0.000795	0.00152	CcSEcCtD
Hydralazine—Palpitations—Capecitabine—stomach cancer	0.00079	0.00151	CcSEcCtD
Hydralazine—Myalgia—Docetaxel—stomach cancer	0.000786	0.0015	CcSEcCtD
Hydralazine—Arthralgia—Docetaxel—stomach cancer	0.000786	0.0015	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—stomach cancer	0.000786	0.0015	CcSEcCtD
Hydralazine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000782	0.0015	CcSEcCtD
Hydralazine—Jaundice—Epirubicin—stomach cancer	0.000777	0.00149	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.000777	0.00338	CbGpPWpGaD
Hydralazine—Conjunctivitis—Epirubicin—stomach cancer	0.000775	0.00148	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—stomach cancer	0.000774	0.00148	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—stomach cancer	0.000774	0.00148	CcSEcCtD
Hydralazine—Hypersensitivity—Fluorouracil—stomach cancer	0.00077	0.00147	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000769	0.00335	CbGpPWpGaD
Hydralazine—Hepatitis—Methotrexate—stomach cancer	0.000765	0.00146	CcSEcCtD
Hydralazine—Myalgia—Capecitabine—stomach cancer	0.000761	0.00146	CcSEcCtD
Hydralazine—Arthralgia—Capecitabine—stomach cancer	0.000761	0.00146	CcSEcCtD
Hydralazine—Haematuria—Epirubicin—stomach cancer	0.00076	0.00145	CcSEcCtD
Hydralazine—Anxiety—Capecitabine—stomach cancer	0.000759	0.00145	CcSEcCtD
Hydralazine—Oedema—Docetaxel—stomach cancer	0.000754	0.00144	CcSEcCtD
Hydralazine—Discomfort—Capecitabine—stomach cancer	0.000752	0.00144	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—stomach cancer	0.000749	0.00143	CcSEcCtD
Hydralazine—Diarrhoea—Irinotecan—stomach cancer	0.000746	0.00143	CcSEcCtD
Hydralazine—Agranulocytosis—Epirubicin—stomach cancer	0.000744	0.00142	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—stomach cancer	0.000742	0.00323	CbGpPWpGaD
Hydralazine—Pruritus—Fluorouracil—stomach cancer	0.000739	0.00141	CcSEcCtD
Hydralazine—Thrombocytopenia—Docetaxel—stomach cancer	0.000738	0.00141	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000738	0.00321	CbGpPWpGaD
Hydralazine—Tachycardia—Docetaxel—stomach cancer	0.000736	0.00141	CcSEcCtD
Hydralazine—Oedema—Capecitabine—stomach cancer	0.00073	0.0014	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000723	0.00138	CcSEcCtD
Hydralazine—Dizziness—Irinotecan—stomach cancer	0.000721	0.00138	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—stomach cancer	0.000719	0.00138	CcSEcCtD
Hydralazine—Anorexia—Docetaxel—stomach cancer	0.000719	0.00137	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—stomach cancer	0.000717	0.00137	CcSEcCtD
Hydralazine—Hepatitis—Epirubicin—stomach cancer	0.000716	0.00137	CcSEcCtD
Hydralazine—Diarrhoea—Fluorouracil—stomach cancer	0.000715	0.00137	CcSEcCtD
Hydralazine—Thrombocytopenia—Capecitabine—stomach cancer	0.000715	0.00137	CcSEcCtD
Hydralazine—Tachycardia—Capecitabine—stomach cancer	0.000712	0.00136	CcSEcCtD
Hydralazine—Hypoaesthesia—Epirubicin—stomach cancer	0.000712	0.00136	CcSEcCtD
Hydralazine—Hypotension—Docetaxel—stomach cancer	0.000704	0.00135	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—stomach cancer	0.000703	0.00135	CcSEcCtD
Hydralazine—Anorexia—Capecitabine—stomach cancer	0.000696	0.00133	CcSEcCtD
Hydralazine—Vomiting—Irinotecan—stomach cancer	0.000693	0.00133	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.000691	0.00301	CbGpPWpGaD
Hydralazine—Dizziness—Fluorouracil—stomach cancer	0.000691	0.00132	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—stomach cancer	0.000688	0.00132	CcSEcCtD
Hydralazine—Rash—Irinotecan—stomach cancer	0.000688	0.00132	CcSEcCtD
Hydralazine—Dermatitis—Irinotecan—stomach cancer	0.000687	0.00131	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000687	0.00131	CcSEcCtD
Hydralazine—Chills—Methotrexate—stomach cancer	0.000686	0.00131	CcSEcCtD
Hydralazine—Headache—Irinotecan—stomach cancer	0.000683	0.00131	CcSEcCtD
Hydralazine—Hypotension—Capecitabine—stomach cancer	0.000682	0.0013	CcSEcCtD
Hydralazine—Paraesthesia—Docetaxel—stomach cancer	0.000677	0.0013	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000677	0.00295	CbGpPWpGaD
Hydralazine—Dyspnoea—Docetaxel—stomach cancer	0.000672	0.00129	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000665	0.00127	CcSEcCtD
Hydralazine—Flushing—Epirubicin—stomach cancer	0.000664	0.00127	CcSEcCtD
Hydralazine—Vomiting—Fluorouracil—stomach cancer	0.000664	0.00127	CcSEcCtD
Hydralazine—Dyspepsia—Docetaxel—stomach cancer	0.000664	0.00127	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—stomach cancer	0.000662	0.00127	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOA1—stomach cancer	0.00066	0.00287	CbGpPWpGaD
Hydralazine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000659	0.00126	CcSEcCtD
Hydralazine—Rash—Fluorouracil—stomach cancer	0.000659	0.00126	CcSEcCtD
Hydralazine—Dermatitis—Fluorouracil—stomach cancer	0.000658	0.00126	CcSEcCtD
Hydralazine—Paraesthesia—Capecitabine—stomach cancer	0.000655	0.00125	CcSEcCtD
Hydralazine—Decreased appetite—Docetaxel—stomach cancer	0.000655	0.00125	CcSEcCtD
Hydralazine—Headache—Fluorouracil—stomach cancer	0.000654	0.00125	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000651	0.00125	CcSEcCtD
Hydralazine—Dyspnoea—Capecitabine—stomach cancer	0.000651	0.00124	CcSEcCtD
Hydralazine—Nausea—Irinotecan—stomach cancer	0.000648	0.00124	CcSEcCtD
Hydralazine—Constipation—Docetaxel—stomach cancer	0.000645	0.00123	CcSEcCtD
Hydralazine—Dyspepsia—Capecitabine—stomach cancer	0.000643	0.00123	CcSEcCtD
Hydralazine—Chills—Epirubicin—stomach cancer	0.000642	0.00123	CcSEcCtD
Hydralazine—Decreased appetite—Capecitabine—stomach cancer	0.000635	0.00121	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00063	0.00121	CcSEcCtD
Hydralazine—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000627	0.00273	CbGpPWpGaD
Hydralazine—Constipation—Capecitabine—stomach cancer	0.000624	0.00119	CcSEcCtD
Hydralazine—Feeling abnormal—Docetaxel—stomach cancer	0.000621	0.00119	CcSEcCtD
Hydralazine—Nausea—Fluorouracil—stomach cancer	0.00062	0.00119	CcSEcCtD
Hydralazine—Ill-defined disorder—Methotrexate—stomach cancer	0.000618	0.00118	CcSEcCtD
Hydralazine—Anaemia—Methotrexate—stomach cancer	0.000615	0.00118	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—stomach cancer	0.000615	0.00118	CcSEcCtD
Hydralazine—Feeling abnormal—Capecitabine—stomach cancer	0.000601	0.00115	CcSEcCtD
Hydralazine—Malaise—Methotrexate—stomach cancer	0.0006	0.00115	CcSEcCtD
Hydralazine—Muscle spasms—Epirubicin—stomach cancer	0.000599	0.00115	CcSEcCtD
Hydralazine—Body temperature increased—Docetaxel—stomach cancer	0.000596	0.00114	CcSEcCtD
Hydralazine—Leukopenia—Methotrexate—stomach cancer	0.000596	0.00114	CcSEcCtD
Hydralazine—Chills—Doxorubicin—stomach cancer	0.000594	0.00114	CcSEcCtD
Hydralazine—Urticaria—Capecitabine—stomach cancer	0.00058	0.00111	CcSEcCtD
Hydralazine—Ill-defined disorder—Epirubicin—stomach cancer	0.000578	0.00111	CcSEcCtD
Hydralazine—Body temperature increased—Capecitabine—stomach cancer	0.000577	0.0011	CcSEcCtD
Hydralazine—Anaemia—Epirubicin—stomach cancer	0.000576	0.0011	CcSEcCtD
Hydralazine—Agitation—Epirubicin—stomach cancer	0.000573	0.0011	CcSEcCtD
Hydralazine—Arthralgia—Methotrexate—stomach cancer	0.000567	0.00108	CcSEcCtD
Hydralazine—Myalgia—Methotrexate—stomach cancer	0.000567	0.00108	CcSEcCtD
Hydralazine—Malaise—Epirubicin—stomach cancer	0.000562	0.00107	CcSEcCtD
Hydralazine—Discomfort—Methotrexate—stomach cancer	0.00056	0.00107	CcSEcCtD
Hydralazine—Leukopenia—Epirubicin—stomach cancer	0.000558	0.00107	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000556	0.00242	CbGpPWpGaD
Hydralazine—Hypersensitivity—Docetaxel—stomach cancer	0.000555	0.00106	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—stomach cancer	0.000554	0.00106	CcSEcCtD
Hydralazine—Palpitations—Epirubicin—stomach cancer	0.000551	0.00105	CcSEcCtD
Hydralazine—Hypersensitivity—Capecitabine—stomach cancer	0.000538	0.00103	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—stomach cancer	0.000535	0.00102	CcSEcCtD
Hydralazine—Pruritus—Docetaxel—stomach cancer	0.000533	0.00102	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—stomach cancer	0.000533	0.00102	CcSEcCtD
Hydralazine—Thrombocytopenia—Methotrexate—stomach cancer	0.000532	0.00102	CcSEcCtD
Hydralazine—Arthralgia—Epirubicin—stomach cancer	0.00053	0.00101	CcSEcCtD
Hydralazine—Myalgia—Epirubicin—stomach cancer	0.00053	0.00101	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—stomach cancer	0.00053	0.00101	CcSEcCtD
Hydralazine—Anxiety—Epirubicin—stomach cancer	0.000529	0.00101	CcSEcCtD
Hydralazine—Discomfort—Epirubicin—stomach cancer	0.000524	0.001	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—stomach cancer	0.000523	0.00228	CbGpPWpGaD
Hydralazine—Malaise—Doxorubicin—stomach cancer	0.00052	0.000995	CcSEcCtD
Hydralazine—Anorexia—Methotrexate—stomach cancer	0.000518	0.000991	CcSEcCtD
Hydralazine—Pruritus—Capecitabine—stomach cancer	0.000516	0.000988	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—stomach cancer	0.000516	0.000987	CcSEcCtD
Hydralazine—Diarrhoea—Docetaxel—stomach cancer	0.000516	0.000987	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—stomach cancer	0.000509	0.000975	CcSEcCtD
Hydralazine—Oedema—Epirubicin—stomach cancer	0.000509	0.000973	CcSEcCtD
Hydralazine—Hypotension—Methotrexate—stomach cancer	0.000508	0.000971	CcSEcCtD
Hydralazine—Diarrhoea—Capecitabine—stomach cancer	0.000499	0.000955	CcSEcCtD
Hydralazine—Dizziness—Docetaxel—stomach cancer	0.000499	0.000954	CcSEcCtD
Hydralazine—Thrombocytopenia—Epirubicin—stomach cancer	0.000498	0.000952	CcSEcCtD
Hydralazine—Tachycardia—Epirubicin—stomach cancer	0.000496	0.000949	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000495	0.000947	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—stomach cancer	0.000491	0.000939	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—stomach cancer	0.000491	0.000939	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—stomach cancer	0.000489	0.000936	CcSEcCtD
Hydralazine—Paraesthesia—Methotrexate—stomach cancer	0.000488	0.000933	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—stomach cancer	0.000485	0.000928	CcSEcCtD
Hydralazine—Anorexia—Epirubicin—stomach cancer	0.000485	0.000927	CcSEcCtD
Hydralazine—Dyspnoea—Methotrexate—stomach cancer	0.000484	0.000927	CcSEcCtD
Hydralazine—Dizziness—Capecitabine—stomach cancer	0.000483	0.000923	CcSEcCtD
Hydralazine—Vomiting—Docetaxel—stomach cancer	0.000479	0.000917	CcSEcCtD
Hydralazine—Dyspepsia—Methotrexate—stomach cancer	0.000478	0.000915	CcSEcCtD
Hydralazine—Rash—Docetaxel—stomach cancer	0.000475	0.000909	CcSEcCtD
Hydralazine—Hypotension—Epirubicin—stomach cancer	0.000475	0.000909	CcSEcCtD
Hydralazine—Dermatitis—Docetaxel—stomach cancer	0.000475	0.000909	CcSEcCtD
Hydralazine—Decreased appetite—Methotrexate—stomach cancer	0.000472	0.000904	CcSEcCtD
Hydralazine—Headache—Docetaxel—stomach cancer	0.000472	0.000904	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—stomach cancer	0.000471	0.0009	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000469	0.000897	CcSEcCtD
Hydralazine—Vomiting—Capecitabine—stomach cancer	0.000464	0.000888	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000463	0.000886	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000461	0.000881	CcSEcCtD
Hydralazine—Rash—Capecitabine—stomach cancer	0.00046	0.00088	CcSEcCtD
Hydralazine—Dermatitis—Capecitabine—stomach cancer	0.00046	0.00088	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—stomach cancer	0.000459	0.000878	CcSEcCtD
Hydralazine—Headache—Capecitabine—stomach cancer	0.000457	0.000875	CcSEcCtD
Hydralazine—Paraesthesia—Epirubicin—stomach cancer	0.000457	0.000874	CcSEcCtD
Hydralazine—Dyspnoea—Epirubicin—stomach cancer	0.000453	0.000867	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—stomach cancer	0.000448	0.000858	CcSEcCtD
Hydralazine—Nausea—Docetaxel—stomach cancer	0.000448	0.000857	CcSEcCtD
Hydralazine—Feeling abnormal—Methotrexate—stomach cancer	0.000448	0.000857	CcSEcCtD
Hydralazine—Dyspepsia—Epirubicin—stomach cancer	0.000448	0.000856	CcSEcCtD
Hydralazine—Decreased appetite—Epirubicin—stomach cancer	0.000442	0.000846	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—stomach cancer	0.00044	0.000841	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000439	0.00084	CcSEcCtD
Hydralazine—Constipation—Epirubicin—stomach cancer	0.000435	0.000832	CcSEcCtD
Hydralazine—Nausea—Capecitabine—stomach cancer	0.000434	0.000829	CcSEcCtD
Hydralazine—Urticaria—Methotrexate—stomach cancer	0.000432	0.000826	CcSEcCtD
Hydralazine—Body temperature increased—Methotrexate—stomach cancer	0.00043	0.000822	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000429	0.00082	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—stomach cancer	0.000422	0.000808	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—stomach cancer	0.000419	0.000802	CcSEcCtD
Hydralazine—Feeling abnormal—Epirubicin—stomach cancer	0.000419	0.000802	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—stomach cancer	0.000414	0.000792	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000409	0.00178	CbGpPWpGaD
Hydralazine—Decreased appetite—Doxorubicin—stomach cancer	0.000409	0.000782	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000406	0.000777	CcSEcCtD
Hydralazine—Urticaria—Epirubicin—stomach cancer	0.000404	0.000773	CcSEcCtD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000404	0.00176	CbGpPWpGaD
Hydralazine—Constipation—Doxorubicin—stomach cancer	0.000402	0.00077	CcSEcCtD
Hydralazine—Body temperature increased—Epirubicin—stomach cancer	0.000402	0.000769	CcSEcCtD
Hydralazine—Hypersensitivity—Methotrexate—stomach cancer	0.0004	0.000766	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—stomach cancer	0.000388	0.000742	CcSEcCtD
Hydralazine—Pruritus—Methotrexate—stomach cancer	0.000384	0.000735	CcSEcCtD
Hydralazine—Hypersensitivity—Epirubicin—stomach cancer	0.000375	0.000717	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—stomach cancer	0.000374	0.000715	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—stomach cancer	0.000372	0.000712	CcSEcCtD
Hydralazine—Diarrhoea—Methotrexate—stomach cancer	0.000372	0.000711	CcSEcCtD
Hydralazine—Pruritus—Epirubicin—stomach cancer	0.00036	0.000688	CcSEcCtD
Hydralazine—Dizziness—Methotrexate—stomach cancer	0.000359	0.000687	CcSEcCtD
Hydralazine—Diarrhoea—Epirubicin—stomach cancer	0.000348	0.000666	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—stomach cancer	0.000347	0.000663	CcSEcCtD
Hydralazine—Vomiting—Methotrexate—stomach cancer	0.000345	0.000661	CcSEcCtD
Hydralazine—Rash—Methotrexate—stomach cancer	0.000343	0.000655	CcSEcCtD
Hydralazine—Dermatitis—Methotrexate—stomach cancer	0.000342	0.000655	CcSEcCtD
Hydralazine—Headache—Methotrexate—stomach cancer	0.00034	0.000651	CcSEcCtD
Hydralazine—Dizziness—Epirubicin—stomach cancer	0.000336	0.000643	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—stomach cancer	0.000333	0.000637	CcSEcCtD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000332	0.00144	CbGpPWpGaD
Hydralazine—Vomiting—Epirubicin—stomach cancer	0.000323	0.000619	CcSEcCtD
Hydralazine—Nausea—Methotrexate—stomach cancer	0.000323	0.000617	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—stomach cancer	0.000322	0.000616	CcSEcCtD
Hydralazine—Rash—Epirubicin—stomach cancer	0.000321	0.000613	CcSEcCtD
Hydralazine—Dermatitis—Epirubicin—stomach cancer	0.00032	0.000613	CcSEcCtD
Hydralazine—Headache—Epirubicin—stomach cancer	0.000319	0.000609	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—stomach cancer	0.000311	0.000595	CcSEcCtD
Hydralazine—Nausea—Epirubicin—stomach cancer	0.000302	0.000578	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—stomach cancer	0.000299	0.000572	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000298	0.0013	CbGpPWpGaD
Hydralazine—Rash—Doxorubicin—stomach cancer	0.000297	0.000568	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—stomach cancer	0.000296	0.000567	CcSEcCtD
Hydralazine—Headache—Doxorubicin—stomach cancer	0.000295	0.000564	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—stomach cancer	0.000279	0.000535	CcSEcCtD
Hydralazine—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000178	0.000776	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000176	0.000767	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000169	0.000736	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTP1—stomach cancer	0.000124	0.000538	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	0.000122	0.000531	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	0.000114	0.000494	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	0.000112	0.000488	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACAD8—stomach cancer	0.000106	0.000463	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GMPR2—stomach cancer	9.47e-05	0.000412	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—IDH3B—stomach cancer	8.66e-05	0.000377	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SUCLG1—stomach cancer	8.66e-05	0.000377	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NDUFS1—stomach cancer	8.05e-05	0.000351	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NDUFV1—stomach cancer	8.05e-05	0.000351	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PGLS—stomach cancer	7.18e-05	0.000312	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BLVRB—stomach cancer	7.18e-05	0.000312	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPAP2A—stomach cancer	6.85e-05	0.000298	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FBP1—stomach cancer	6.1e-05	0.000266	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA1—stomach cancer	6.1e-05	0.000266	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CKB—stomach cancer	6.1e-05	0.000266	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NDUFA2—stomach cancer	6.1e-05	0.000266	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLIN2—stomach cancer	5.74e-05	0.00025	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA2—stomach cancer	5.58e-05	0.000243	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PGAM1—stomach cancer	5.44e-05	0.000237	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NT5E—stomach cancer	5.44e-05	0.000237	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLCE1—stomach cancer	5.19e-05	0.000226	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	5.19e-05	0.000226	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UMPS—stomach cancer	4.97e-05	0.000217	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PDHA1—stomach cancer	4.62e-05	0.000201	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ECHS1—stomach cancer	4.62e-05	0.000201	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TYMP—stomach cancer	4.35e-05	0.000189	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FADS1—stomach cancer	4.35e-05	0.000189	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SREBF2—stomach cancer	4.07e-05	0.000177	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—RORA—stomach cancer	4.02e-05	0.000175	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDOB—stomach cancer	3.77e-05	0.000164	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALOX5—stomach cancer	3.5e-05	0.000153	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DPYD—stomach cancer	3.45e-05	0.00015	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTT1—stomach cancer	3.05e-05	0.000133	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.01e-05	0.000131	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.93e-05	0.000128	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ENO1—stomach cancer	2.86e-05	0.000124	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CD44—stomach cancer	2.53e-05	0.00011	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.15e-05	9.38e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTP1—stomach cancer	2.11e-05	9.2e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—stomach cancer	2.08e-05	9.08e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TYMS—stomach cancer	1.96e-05	8.56e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTM1—stomach cancer	1.94e-05	8.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ERCC2—stomach cancer	1.83e-05	7.95e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTHFR—stomach cancer	1.72e-05	7.47e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAV1—stomach cancer	1.58e-05	6.89e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA1—stomach cancer	1.58e-05	6.88e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—stomach cancer	1.39e-05	6.06e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—stomach cancer	1.25e-05	5.45e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—stomach cancer	1.2e-05	5.21e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.09e-05	4.77e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3CA—stomach cancer	6.74e-06	2.93e-05	CbGpPWpGaD
